Coya Therapeutics, Inc.
Coya Therapeutics, Inc. (NASDAQ: COYA) is trading at $4.99, about ₹483 at today's USD/INR rate, as of 8 Oct 2026, 4:00 PM ET, up 1.63% today. Indian residents can buy Coya Therapeutics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$4.72
Today's high
$5.00
52 week low
$3.71
52 week high
$7.75
COYA opened at $4.91, closed previously at $4.91, and has traded between $3.71 and $7.75 over the past 52 weeks.
About
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at treating Frontotemporal Dementia. Meanwhile, COYA 302 is a dual-action biologic combination, suitable for subcutaneous or intravenous delivery, engineered to not only boost Treg function but also to diminish harmful T effector cell activity and activated macrophages in neurodegenerative and autoimmune disorders. Additionally, Coya has earlier-stage programs, including COYA 201, an allogeneic (off-the-shelf) Treg exosome candidate in preclinical development for a range of neurodegenerative, autoimmune, and metabolic conditions. Its pipeline also features COYA 206, an antigen-directed Treg-derived exosome product, currently in the discovery phase. Established in 2020, Coya Therapeutics maintains its headquarters in Houston, Texas.
Key statistics
Avg. volume
176.06K
Market cap
$117.05M
P/E Ratio
-4.66
Price-to-sales ratio
14.60
Enterprise value
$50.21M
Free cash flow yield
-11.07%
Debt-to-equity ratio
0.00
Return on equity
-49.33%
ROIC
-45.98%
Beta
0.58
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$7.95M
Earnings per share
-$1.27
Free cash flow
-$10.74M
Net profit margin
-270.22%
Gross margin
99.91%
EBITDA
-$21.20M
Revenue growth
123.57%
Similar securities
This is not an investment recommendation
How to buy Coya Therapeutics from India
Indian residents can buy Coya Therapeutics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers. Read the full guide: how to invest in Coya Therapeutics from India
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Coya Therapeutics and place an order
Find Coya Therapeutics by name or by its ticker, COYA, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Coya Therapeutics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Coya Therapeutics position in USD and INR. Coya Therapeutics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Trading and taxes when buying Coya Therapeutics from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneCoya Therapeutics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
FAQs
Can Indian residents buy Coya Therapeutics stock?
Yes. Coya Therapeutics (COYA) has been listed on NASDAQ since 2022, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Coya Therapeutics share cost in rupees?
One Coya Therapeutics share is $4.99 — about ₹483 at a USD/INR rate of 96.88 on 8 Oct 2026. Both the Coya Therapeutics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Coya Therapeutics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Coya Therapeutics?
Yes. One Coya Therapeutics share is $4.99, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Coya Therapeutics.
How are gains on Coya Therapeutics shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Coya Therapeutics price. Paasa issues a capital-gains statement for your return.
Does Coya Therapeutics pay a dividend?
No. Coya Therapeutics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Coya Therapeutics from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Coya Therapeutics shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Coya Therapeutics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Coya Therapeutics holding, its cost and its closing value.
How do I sell Coya Therapeutics and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.